Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-08-24

AUTHORS

Seung-Pyo Lee, Jung-Won Suh, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Whan Bae, Myeong-Chan Cho, Taek-Geun Kwon, Jang-Ho Bae, Hyo-Soo Kim

ABSTRACT

BACKGROUND: Current guidelines recommend dual anti-platelet therapy, aspirin and clopidogrel, for patients treated with drug-eluting stent for coronary heart disease. In a few small trials, addition of cilostazol on dual anti-platelet therapy (triple anti-platelet therapy) showed better late luminal loss. In the real-world unselected patients with coronary heart disease, however, the effect of cilostazol on platelet reactivity and ischemic vascular events after drug-eluting stent implantation has not been tested. It is also controversial whether there is a significant interaction between lipophilic statin and clopidogrel. METHODS/DESIGN: CILON-T trial was a prospective, randomized, open-label, multi-center, near-all-comer trial to demonstrate the superiority of triple anti-platelet therapy to dual anti-platelet therapy in reducing 6 months' major adverse cardiovascular/cerebrovascular events, composite of cardiac death, nonfatal myocardial infarction, target lesion revascularization and ischemic stroke. It also tested whether triple anti-platelet therapy is superior to dual anti-platelet therapy in inhibiting platelet reactivity in patients receiving percutaneous coronary intervention with drug-eluting stent. Total 960 patients were randomized to receive either dual anti-platelet therapy or triple anti-platelet therapy for 6 months and also, randomly stratified to either lipophilic statin (atorvastatin) or non-lipophilic statin (rosuvastatin) indefinitely. Secondary endpoints included all components of major adverse cardiovascular/cerebrovascular events, platelet reactivity as assessed by VerifyNow P2Y12 assay, effect of statin on major adverse cardiovascular/cerebrovascular events, bleeding complications, and albumin-to-creatinine ratio to test the nephroprotective effect of cilostazol. Major adverse cardiovascular/cerebrovascular events will also be checked at 1, 2, and 3 years to test the 'legacy' effect of triple anti-platelet therapy that was prescribed for only 6 months after percutaneous coronary intervention. DISCUSSION: CILON-T trial will give powerful insight into whether triple anti-platelet therapy is superior to dual anti-platelet therapy in reducing ischemic events and platelet reactivity in the real-world unselected patients treated with drug-eluting stent for coronary heart disease. Also, it will verify the laboratory and clinical significance of drug interaction between lipophilic statin and clopidogrel. TRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier# NCT00776828). More... »

PAGES

87-87

References to SciGraph publications

  • 1999-12. Effects of CYP3A Inhibition on the Metabolism of Cilostazol in CLINICAL PHARMACOKINETICS
  • 1999-12. Effect of Omeprazole on the Metabolism of Cilostazol in CLINICAL PHARMACOKINETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/1745-6215-11-87

    DOI

    http://dx.doi.org/10.1186/1745-6215-11-87

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1009096312

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20735821


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angioplasty, Balloon, Coronary", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aspirin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Ischemia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cilostazol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clinical Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clopidogrel", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Interactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Therapy, Combination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug-Eluting Stents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myocardial Infarction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Myocardial Ischemia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Platelet Aggregation Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prosthesis Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Republic of Korea", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Research Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stroke", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tetrazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ticlopidine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Time Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Seung-Pyo", 
            "id": "sg:person.01335535736.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335535736.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412480.b", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
                "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Suh", 
            "givenName": "Jung-Won", 
            "id": "sg:person.01221307336.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221307336.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Park", 
            "givenName": "Kyung Woo", 
            "id": "sg:person.0755760133.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755760133.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lee", 
            "givenName": "Hae-Young", 
            "id": "sg:person.01147373015.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147373015.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kang", 
            "givenName": "Hyun-Jae", 
            "id": "sg:person.01254550333.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254550333.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Koo", 
            "givenName": "Bon-Kwon", 
            "id": "sg:person.01031167354.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031167354.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412480.b", 
              "name": [
                "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chae", 
            "givenName": "In-Ho", 
            "id": "sg:person.0750274114.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750274114.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412480.b", 
              "name": [
                "Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Choi", 
            "givenName": "Dong-Ju", 
            "id": "sg:person.01140400105.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140400105.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411134.2", 
              "name": [
                "Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rha", 
            "givenName": "Seung-Woon", 
            "id": "sg:person.0727476565.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727476565.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411725.4", 
              "name": [
                "Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bae", 
            "givenName": "Jang-Whan", 
            "id": "sg:person.0770120366.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770120366.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411725.4", 
              "name": [
                "Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cho", 
            "givenName": "Myeong-Chan", 
            "id": "sg:person.01224452677.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224452677.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Konyang University Hospital, Daejeon, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411127.0", 
              "name": [
                "Konyang University Hospital, Daejeon, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kwon", 
            "givenName": "Taek-Geun", 
            "id": "sg:person.01313343214.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313343214.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Konyang University Hospital, Daejeon, Korea", 
              "id": "http://www.grid.ac/institutes/grid.411127.0", 
              "name": [
                "Konyang University Hospital, Daejeon, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bae", 
            "givenName": "Jang-Ho", 
            "id": "sg:person.01272566077.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272566077.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.412484.f", 
              "name": [
                "Cardiovascular Center, Seoul National University Hospital, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kim", 
            "givenName": "Hyo-Soo", 
            "id": "sg:person.010705376560.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010705376560.19"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00003088-199937002-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035219731", 
              "https://doi.org/10.2165/00003088-199937002-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199937002-00007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002413486", 
              "https://doi.org/10.2165/00003088-199937002-00007"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2010-08-24", 
        "datePublishedReg": "2010-08-24", 
        "description": "BACKGROUND: Current guidelines recommend dual anti-platelet therapy, aspirin and clopidogrel, for patients treated with drug-eluting stent for coronary heart disease. In a few small trials, addition of cilostazol on dual anti-platelet therapy (triple anti-platelet therapy) showed better late luminal loss. In the real-world unselected patients with coronary heart disease, however, the effect of cilostazol on platelet reactivity and ischemic vascular events after drug-eluting stent implantation has not been tested. It is also controversial whether there is a significant interaction between lipophilic statin and clopidogrel.\nMETHODS/DESIGN: CILON-T trial was a prospective, randomized, open-label, multi-center, near-all-comer trial to demonstrate the superiority of triple anti-platelet therapy to dual anti-platelet therapy in reducing 6 months' major adverse cardiovascular/cerebrovascular events, composite of cardiac death, nonfatal myocardial infarction, target lesion revascularization and ischemic stroke. It also tested whether triple anti-platelet therapy is superior to dual anti-platelet therapy in inhibiting platelet reactivity in patients receiving percutaneous coronary intervention with drug-eluting stent. Total 960 patients were randomized to receive either dual anti-platelet therapy or triple anti-platelet therapy for 6 months and also, randomly stratified to either lipophilic statin (atorvastatin) or non-lipophilic statin (rosuvastatin) indefinitely. Secondary endpoints included all components of major adverse cardiovascular/cerebrovascular events, platelet reactivity as assessed by VerifyNow P2Y12 assay, effect of statin on major adverse cardiovascular/cerebrovascular events, bleeding complications, and albumin-to-creatinine ratio to test the nephroprotective effect of cilostazol. Major adverse cardiovascular/cerebrovascular events will also be checked at 1, 2, and 3 years to test the 'legacy' effect of triple anti-platelet therapy that was prescribed for only 6 months after percutaneous coronary intervention.\nDISCUSSION: CILON-T trial will give powerful insight into whether triple anti-platelet therapy is superior to dual anti-platelet therapy in reducing ischemic events and platelet reactivity in the real-world unselected patients treated with drug-eluting stent for coronary heart disease. Also, it will verify the laboratory and clinical significance of drug interaction between lipophilic statin and clopidogrel.\nTRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier# NCT00776828).", 
        "genre": "article", 
        "id": "sg:pub.10.1186/1745-6215-11-87", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1297400", 
            "issn": [
              "1468-6708", 
              "1745-6215"
            ], 
            "name": "Trials", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "11"
          }
        ], 
        "keywords": [
          "triple anti-platelet therapy", 
          "dual anti-platelet therapy", 
          "drug-eluting stent implantation", 
          "anti-platelet therapy", 
          "coronary heart disease", 
          "drug-eluting stents", 
          "percutaneous coronary intervention", 
          "cerebrovascular events", 
          "platelet reactivity", 
          "heart disease", 
          "stent implantation", 
          "lipophilic statins", 
          "coronary intervention", 
          "Health Clinical Trials Registry", 
          "influence of cilostazol", 
          "ischemic vascular complications", 
          "ischemic vascular events", 
          "nonfatal myocardial infarction", 
          "addition of cilostazol", 
          "late luminal loss", 
          "Clinical Trials Registry", 
          "efficacy of cilostazol", 
          "effect of cilostazol", 
          "effect of statins", 
          "VerifyNow P2Y12", 
          "lesion revascularization", 
          "Secondary endpoints", 
          "ischemic complications", 
          "vascular events", 
          "nephroprotective effect", 
          "ischemic events", 
          "vascular complications", 
          "ischemic stroke", 
          "Trials Registry", 
          "luminal loss", 
          "cardiac death", 
          "creatinine ratio", 
          "comers trial", 
          "small trials", 
          "myocardial infarction", 
          "current guidelines", 
          "drug interactions", 
          "clinical significance", 
          "statins", 
          "patients", 
          "cilostazol", 
          "therapy", 
          "clopidogrel", 
          "complications", 
          "study design", 
          "disease", 
          "trials", 
          "stents", 
          "CILON", 
          "National Institute", 
          "months", 
          "implantation", 
          "intervention", 
          "significant interaction", 
          "multicenter", 
          "revascularization", 
          "infarction", 
          "aspirin", 
          "P2Y12", 
          "registry", 
          "stroke", 
          "endpoint", 
          "events", 
          "efficacy", 
          "death", 
          "effect", 
          "reactivity", 
          "albumin", 
          "guidelines", 
          "years", 
          "rationale", 
          "significance", 
          "study", 
          "Institute", 
          "loss", 
          "addition", 
          "laboratory", 
          "ratio", 
          "interaction", 
          "components", 
          "insights", 
          "superiority", 
          "powerful insights", 
          "influence", 
          "design", 
          "legacy", 
          "better late luminal loss", 
          "non-lipophilic statin"
        ], 
        "name": "Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease", 
        "pagination": "87-87", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1009096312"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/1745-6215-11-87"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20735821"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/1745-6215-11-87", 
          "https://app.dimensions.ai/details/publication/pub.1009096312"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T18:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_509.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/1745-6215-11-87"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-11-87'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-11-87'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-11-87'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-11-87'


     

    This table displays all metadata directly associated to this object as RDF triples.

    359 TRIPLES      22 PREDICATES      144 URIs      134 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/1745-6215-11-87 schema:about N009618f209d3417990817c57294d9263
    2 N0c9d07eac64f4deea17afa93271f7733
    3 N131a55f8356b484e9777c4874f445b6e
    4 N1d202a7d227543af9ecaaa67529d2598
    5 N2a810890344f42b9b5d0ce9a624a0212
    6 N301fb0fac613434bacddc76e6a4bb9ba
    7 N361da9c628c8450981014a921b013bb1
    8 N395025455984465e90f78e5b784e996e
    9 N3ce761ee66ed4d008b1d568522d7ee77
    10 N463efd1852264d80a0936f78e0d9a526
    11 N57dca2449dc24626b69c9417715276de
    12 N6455260073084613bdca59fce4421da3
    13 N737dba44a5b64f92b074cbb0a89464fa
    14 N85fecb8dcacd4aacb976afb4ac095c2b
    15 N86556a634f764ae8862cb2a3395c41ae
    16 N982edad08f6743b2ae107b253b1510fe
    17 N9b8c001c82164432b647fc5217402e85
    18 Nae1a05ab0fe14dcba6f81538a025b515
    19 Nb4c4948111ff428fbbbdbd8a28440599
    20 Nb57e4ff948374bfda71686041ac6e95e
    21 Ncc3cfde5ea354b23bb05c21aa262b048
    22 Nd9650df672384138b0e6a1988192564d
    23 Neec5478a54c54b5fa502eacd1d747ca0
    24 anzsrc-for:11
    25 anzsrc-for:1102
    26 schema:author N84f045c1fb0549c89bd688ea78d4447e
    27 schema:citation sg:pub.10.2165/00003088-199937002-00006
    28 sg:pub.10.2165/00003088-199937002-00007
    29 schema:datePublished 2010-08-24
    30 schema:datePublishedReg 2010-08-24
    31 schema:description BACKGROUND: Current guidelines recommend dual anti-platelet therapy, aspirin and clopidogrel, for patients treated with drug-eluting stent for coronary heart disease. In a few small trials, addition of cilostazol on dual anti-platelet therapy (triple anti-platelet therapy) showed better late luminal loss. In the real-world unselected patients with coronary heart disease, however, the effect of cilostazol on platelet reactivity and ischemic vascular events after drug-eluting stent implantation has not been tested. It is also controversial whether there is a significant interaction between lipophilic statin and clopidogrel. METHODS/DESIGN: CILON-T trial was a prospective, randomized, open-label, multi-center, near-all-comer trial to demonstrate the superiority of triple anti-platelet therapy to dual anti-platelet therapy in reducing 6 months' major adverse cardiovascular/cerebrovascular events, composite of cardiac death, nonfatal myocardial infarction, target lesion revascularization and ischemic stroke. It also tested whether triple anti-platelet therapy is superior to dual anti-platelet therapy in inhibiting platelet reactivity in patients receiving percutaneous coronary intervention with drug-eluting stent. Total 960 patients were randomized to receive either dual anti-platelet therapy or triple anti-platelet therapy for 6 months and also, randomly stratified to either lipophilic statin (atorvastatin) or non-lipophilic statin (rosuvastatin) indefinitely. Secondary endpoints included all components of major adverse cardiovascular/cerebrovascular events, platelet reactivity as assessed by VerifyNow P2Y12 assay, effect of statin on major adverse cardiovascular/cerebrovascular events, bleeding complications, and albumin-to-creatinine ratio to test the nephroprotective effect of cilostazol. Major adverse cardiovascular/cerebrovascular events will also be checked at 1, 2, and 3 years to test the 'legacy' effect of triple anti-platelet therapy that was prescribed for only 6 months after percutaneous coronary intervention. DISCUSSION: CILON-T trial will give powerful insight into whether triple anti-platelet therapy is superior to dual anti-platelet therapy in reducing ischemic events and platelet reactivity in the real-world unselected patients treated with drug-eluting stent for coronary heart disease. Also, it will verify the laboratory and clinical significance of drug interaction between lipophilic statin and clopidogrel. TRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier# NCT00776828).
    32 schema:genre article
    33 schema:inLanguage en
    34 schema:isAccessibleForFree true
    35 schema:isPartOf N1247fa6ef66c458d82e6a90057358523
    36 N4c8bd29b5947405f8b45ecf29caf2c08
    37 sg:journal.1297400
    38 schema:keywords CILON
    39 Clinical Trials Registry
    40 Health Clinical Trials Registry
    41 Institute
    42 National Institute
    43 P2Y12
    44 Secondary endpoints
    45 Trials Registry
    46 VerifyNow P2Y12
    47 addition
    48 addition of cilostazol
    49 albumin
    50 anti-platelet therapy
    51 aspirin
    52 better late luminal loss
    53 cardiac death
    54 cerebrovascular events
    55 cilostazol
    56 clinical significance
    57 clopidogrel
    58 comers trial
    59 complications
    60 components
    61 coronary heart disease
    62 coronary intervention
    63 creatinine ratio
    64 current guidelines
    65 death
    66 design
    67 disease
    68 drug interactions
    69 drug-eluting stent implantation
    70 drug-eluting stents
    71 dual anti-platelet therapy
    72 effect
    73 effect of cilostazol
    74 effect of statins
    75 efficacy
    76 efficacy of cilostazol
    77 endpoint
    78 events
    79 guidelines
    80 heart disease
    81 implantation
    82 infarction
    83 influence
    84 influence of cilostazol
    85 insights
    86 interaction
    87 intervention
    88 ischemic complications
    89 ischemic events
    90 ischemic stroke
    91 ischemic vascular complications
    92 ischemic vascular events
    93 laboratory
    94 late luminal loss
    95 legacy
    96 lesion revascularization
    97 lipophilic statins
    98 loss
    99 luminal loss
    100 months
    101 multicenter
    102 myocardial infarction
    103 nephroprotective effect
    104 non-lipophilic statin
    105 nonfatal myocardial infarction
    106 patients
    107 percutaneous coronary intervention
    108 platelet reactivity
    109 powerful insights
    110 ratio
    111 rationale
    112 reactivity
    113 registry
    114 revascularization
    115 significance
    116 significant interaction
    117 small trials
    118 statins
    119 stent implantation
    120 stents
    121 stroke
    122 study
    123 study design
    124 superiority
    125 therapy
    126 trials
    127 triple anti-platelet therapy
    128 vascular complications
    129 vascular events
    130 years
    131 schema:name Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease
    132 schema:pagination 87-87
    133 schema:productId N218cb2c671a845a7bfc6dc511f8d6697
    134 N3965ce6253ae4b0db1bd32550bda0f9c
    135 Nb4da73f727e540b5971a8a2f743b2d73
    136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009096312
    137 https://doi.org/10.1186/1745-6215-11-87
    138 schema:sdDatePublished 2022-01-01T18:23
    139 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    140 schema:sdPublisher Nd99a0e47d15f42a9b3b996a7640ef091
    141 schema:url https://doi.org/10.1186/1745-6215-11-87
    142 sgo:license sg:explorer/license/
    143 sgo:sdDataset articles
    144 rdf:type schema:ScholarlyArticle
    145 N009618f209d3417990817c57294d9263 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Research Design
    147 rdf:type schema:DefinedTerm
    148 N0c9d07eac64f4deea17afa93271f7733 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Ticlopidine
    150 rdf:type schema:DefinedTerm
    151 N1247fa6ef66c458d82e6a90057358523 schema:issueNumber 1
    152 rdf:type schema:PublicationIssue
    153 N131a55f8356b484e9777c4874f445b6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Myocardial Infarction
    155 rdf:type schema:DefinedTerm
    156 N1d202a7d227543af9ecaaa67529d2598 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Clopidogrel
    158 rdf:type schema:DefinedTerm
    159 N218cb2c671a845a7bfc6dc511f8d6697 schema:name pubmed_id
    160 schema:value 20735821
    161 rdf:type schema:PropertyValue
    162 N2a810890344f42b9b5d0ce9a624a0212 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Brain Ischemia
    164 rdf:type schema:DefinedTerm
    165 N301fb0fac613434bacddc76e6a4bb9ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Drug Therapy, Combination
    167 rdf:type schema:DefinedTerm
    168 N361da9c628c8450981014a921b013bb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Time Factors
    170 rdf:type schema:DefinedTerm
    171 N395025455984465e90f78e5b784e996e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Drug-Eluting Stents
    173 rdf:type schema:DefinedTerm
    174 N3965ce6253ae4b0db1bd32550bda0f9c schema:name doi
    175 schema:value 10.1186/1745-6215-11-87
    176 rdf:type schema:PropertyValue
    177 N3ce761ee66ed4d008b1d568522d7ee77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Myocardial Ischemia
    179 rdf:type schema:DefinedTerm
    180 N463efd1852264d80a0936f78e0d9a526 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Aspirin
    182 rdf:type schema:DefinedTerm
    183 N4c8bd29b5947405f8b45ecf29caf2c08 schema:volumeNumber 11
    184 rdf:type schema:PublicationVolume
    185 N57dca2449dc24626b69c9417715276de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Prospective Studies
    187 rdf:type schema:DefinedTerm
    188 N6455260073084613bdca59fce4421da3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
    190 rdf:type schema:DefinedTerm
    191 N6f737b9c9a5742809658b4c87a2ce3b1 rdf:first sg:person.01224452677.69
    192 rdf:rest Nf8d62483f1ac4dce9afd3b7e57f371a2
    193 N71aef85a708945aaa2f5fee68100183d rdf:first sg:person.010705376560.19
    194 rdf:rest rdf:nil
    195 N737dba44a5b64f92b074cbb0a89464fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Drug Interactions
    197 rdf:type schema:DefinedTerm
    198 N7d9720783e744cb1b8f3fa7c5289885b rdf:first sg:person.0727476565.10
    199 rdf:rest Nc13c646a31ef43fe98743d9027132c98
    200 N7fc86789b0c54c0585ed31906675890f rdf:first sg:person.01031167354.17
    201 rdf:rest Nbfdf04d5365c471ca03aaf3829fca002
    202 N84f045c1fb0549c89bd688ea78d4447e rdf:first sg:person.01335535736.02
    203 rdf:rest Ncb1fb5462bdd458b85afb6231fff7569
    204 N85fecb8dcacd4aacb976afb4ac095c2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Prosthesis Design
    206 rdf:type schema:DefinedTerm
    207 N86556a634f764ae8862cb2a3395c41ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    208 schema:name Cilostazol
    209 rdf:type schema:DefinedTerm
    210 N8fd69afe7fc44ab1992de295d78e792b rdf:first sg:person.01254550333.69
    211 rdf:rest N7fc86789b0c54c0585ed31906675890f
    212 N956ae165412045f2bf225379b50bdde9 rdf:first sg:person.0755760133.30
    213 rdf:rest Na4acb65c5ffb4ba68a883048670feef9
    214 N962a5ba885ad4547b6f961547c8f6347 rdf:first sg:person.01272566077.05
    215 rdf:rest N71aef85a708945aaa2f5fee68100183d
    216 N982edad08f6743b2ae107b253b1510fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Treatment Outcome
    218 rdf:type schema:DefinedTerm
    219 N9b8c001c82164432b647fc5217402e85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name Stroke
    221 rdf:type schema:DefinedTerm
    222 Na4acb65c5ffb4ba68a883048670feef9 rdf:first sg:person.01147373015.99
    223 rdf:rest N8fd69afe7fc44ab1992de295d78e792b
    224 Nae1a05ab0fe14dcba6f81538a025b515 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Republic of Korea
    226 rdf:type schema:DefinedTerm
    227 Nb4c4948111ff428fbbbdbd8a28440599 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Platelet Aggregation Inhibitors
    229 rdf:type schema:DefinedTerm
    230 Nb4da73f727e540b5971a8a2f743b2d73 schema:name dimensions_id
    231 schema:value pub.1009096312
    232 rdf:type schema:PropertyValue
    233 Nb57e4ff948374bfda71686041ac6e95e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Tetrazoles
    235 rdf:type schema:DefinedTerm
    236 Nbfdf04d5365c471ca03aaf3829fca002 rdf:first sg:person.0750274114.26
    237 rdf:rest Nd6605b0e35c74943b4d363836259255e
    238 Nc13c646a31ef43fe98743d9027132c98 rdf:first sg:person.0770120366.15
    239 rdf:rest N6f737b9c9a5742809658b4c87a2ce3b1
    240 Ncb1fb5462bdd458b85afb6231fff7569 rdf:first sg:person.01221307336.14
    241 rdf:rest N956ae165412045f2bf225379b50bdde9
    242 Ncc3cfde5ea354b23bb05c21aa262b048 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    243 schema:name Clinical Protocols
    244 rdf:type schema:DefinedTerm
    245 Nd6605b0e35c74943b4d363836259255e rdf:first sg:person.01140400105.84
    246 rdf:rest N7d9720783e744cb1b8f3fa7c5289885b
    247 Nd9650df672384138b0e6a1988192564d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    248 schema:name Angioplasty, Balloon, Coronary
    249 rdf:type schema:DefinedTerm
    250 Nd99a0e47d15f42a9b3b996a7640ef091 schema:name Springer Nature - SN SciGraph project
    251 rdf:type schema:Organization
    252 Neec5478a54c54b5fa502eacd1d747ca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    253 schema:name Humans
    254 rdf:type schema:DefinedTerm
    255 Nf8d62483f1ac4dce9afd3b7e57f371a2 rdf:first sg:person.01313343214.43
    256 rdf:rest N962a5ba885ad4547b6f961547c8f6347
    257 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    258 schema:name Medical and Health Sciences
    259 rdf:type schema:DefinedTerm
    260 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    261 schema:name Cardiorespiratory Medicine and Haematology
    262 rdf:type schema:DefinedTerm
    263 sg:journal.1297400 schema:issn 1468-6708
    264 1745-6215
    265 schema:name Trials
    266 schema:publisher Springer Nature
    267 rdf:type schema:Periodical
    268 sg:person.01031167354.17 schema:affiliation grid-institutes:grid.412484.f
    269 schema:familyName Koo
    270 schema:givenName Bon-Kwon
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031167354.17
    272 rdf:type schema:Person
    273 sg:person.010705376560.19 schema:affiliation grid-institutes:grid.412484.f
    274 schema:familyName Kim
    275 schema:givenName Hyo-Soo
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010705376560.19
    277 rdf:type schema:Person
    278 sg:person.01140400105.84 schema:affiliation grid-institutes:grid.412480.b
    279 schema:familyName Choi
    280 schema:givenName Dong-Ju
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140400105.84
    282 rdf:type schema:Person
    283 sg:person.01147373015.99 schema:affiliation grid-institutes:grid.412484.f
    284 schema:familyName Lee
    285 schema:givenName Hae-Young
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147373015.99
    287 rdf:type schema:Person
    288 sg:person.01221307336.14 schema:affiliation grid-institutes:grid.412480.b
    289 schema:familyName Suh
    290 schema:givenName Jung-Won
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221307336.14
    292 rdf:type schema:Person
    293 sg:person.01224452677.69 schema:affiliation grid-institutes:grid.411725.4
    294 schema:familyName Cho
    295 schema:givenName Myeong-Chan
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224452677.69
    297 rdf:type schema:Person
    298 sg:person.01254550333.69 schema:affiliation grid-institutes:grid.412484.f
    299 schema:familyName Kang
    300 schema:givenName Hyun-Jae
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254550333.69
    302 rdf:type schema:Person
    303 sg:person.01272566077.05 schema:affiliation grid-institutes:grid.411127.0
    304 schema:familyName Bae
    305 schema:givenName Jang-Ho
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272566077.05
    307 rdf:type schema:Person
    308 sg:person.01313343214.43 schema:affiliation grid-institutes:grid.411127.0
    309 schema:familyName Kwon
    310 schema:givenName Taek-Geun
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313343214.43
    312 rdf:type schema:Person
    313 sg:person.01335535736.02 schema:affiliation grid-institutes:grid.412484.f
    314 schema:familyName Lee
    315 schema:givenName Seung-Pyo
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335535736.02
    317 rdf:type schema:Person
    318 sg:person.0727476565.10 schema:affiliation grid-institutes:grid.411134.2
    319 schema:familyName Rha
    320 schema:givenName Seung-Woon
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727476565.10
    322 rdf:type schema:Person
    323 sg:person.0750274114.26 schema:affiliation grid-institutes:grid.412480.b
    324 schema:familyName Chae
    325 schema:givenName In-Ho
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750274114.26
    327 rdf:type schema:Person
    328 sg:person.0755760133.30 schema:affiliation grid-institutes:grid.412484.f
    329 schema:familyName Park
    330 schema:givenName Kyung Woo
    331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755760133.30
    332 rdf:type schema:Person
    333 sg:person.0770120366.15 schema:affiliation grid-institutes:grid.411725.4
    334 schema:familyName Bae
    335 schema:givenName Jang-Whan
    336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770120366.15
    337 rdf:type schema:Person
    338 sg:pub.10.2165/00003088-199937002-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035219731
    339 https://doi.org/10.2165/00003088-199937002-00006
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.2165/00003088-199937002-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002413486
    342 https://doi.org/10.2165/00003088-199937002-00007
    343 rdf:type schema:CreativeWork
    344 grid-institutes:grid.411127.0 schema:alternateName Konyang University Hospital, Daejeon, Korea
    345 schema:name Konyang University Hospital, Daejeon, Korea
    346 rdf:type schema:Organization
    347 grid-institutes:grid.411134.2 schema:alternateName Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea
    348 schema:name Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea
    349 rdf:type schema:Organization
    350 grid-institutes:grid.411725.4 schema:alternateName Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea
    351 schema:name Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea
    352 rdf:type schema:Organization
    353 grid-institutes:grid.412480.b schema:alternateName Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea
    354 schema:name Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea
    355 Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
    356 rdf:type schema:Organization
    357 grid-institutes:grid.412484.f schema:alternateName Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
    358 schema:name Cardiovascular Center, Seoul National University Hospital, Seoul, Korea
    359 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...